Skip to main content
OpenTrials
Completed

NCT Number: NCT02077647

Focused Registry on the Conservative Treatment of Osteoarthritis of the Knee

The primary objective of this registry is to assess the functional outcome measured with the Knee Injury and Osteoarthritis Outcome Score (KOOS) for patients with medial unicompartmental osteoarthritis and osteonecrosis of the knee treated conservatively. The aim of the Focused Registry is to complete the data collection and enable a sound analysis for the Tomofix Small size study.

Completed

Looking for future studies?

Notify Me

Key information

Age range

40 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Nagasaki University, Nagasaki, Japan

Loading trial locations.

About this study

The aim of the Focused Registry is to complete the data collection and enable a sound analysis for the Tomofix Small size study.

The incidence of knee osteoarthritis (OA) is higher in Japan than in other populations. Respective prevalences of 47.0 and 70.2% in men and women for Kellgren-Lawrence Grades 2-4 knee OA are reported in Japanese patients aged 60 years and over.

First treatment options are pharmacological (i.e. NSAIDs) and non-pharmacological therapies (i.e. use of assistive devices, exercises, osteopathy, physical therapy), followed by injections of hyaluronic acid and other substances. If no such therapies are successful, surgical treatment options as unicompartmental knee replacement, total knee arthroplasty and high tibial osteotomy (HTO) are recognized. The discussion of which is the best therapy is still controversial. HTO may decrease the number of complications compared to total knee replacement or unicompartmental knee arthroplasty and leave the option for later replacement surgery.

In this project, patients are included who would be surgically treated with HTO with Tomofix small based on the investigator's assessment but refuse to have surgical treatment. They will be treated conservatively and are investigated to serve as reference to an ongoing clinical study investigating invasive treatment modalities.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 40 years of age and older
  • Patients with OA Grade 1-4 (Kellgren-Lawrence) or osteonecrosis (ON) Stage 2-4 (according to the Koshino classification)
  • Indication for open wedge HTO with the TomoFix™ Small
  • No ligamental laxity
  • Able to understand and read country national language at an elementary level
  • Ability to understand the content of the patient information / informed consent form
  • Willingness and ability to participate in the registry according to the registry plan (RP)
  • Signed and dated IRB/EC-approved written informed consent

Exclusion criteria

  • Femoro-tibial angle (FTA) > 190° (standing view x-ray)
  • Flexion contracture > 15°
  • Total knee replacement or unicompartmental knee on the contralateral side
  • Infections located between the middle of the femur and the ankle
  • Systemic bacterial infections
  • Severe osteoarthritis or surgery of the hip joint
  • Smoking of more than 20 cigarettes per day
  • Immunodeficiency or compromised host
  • Patients who have participated in any other device or drug related clinical trial within the previous month
  • ACL/PCL reconstruction of the same knee
  • Severe osteoarthritis of the ipsilateral ankle joint
  • HTO on the contralateral side
  • Major surgery on both knees (minor surgery as arthroscopic meniscectomy and synovectomy is allowed)

Treatment and study plan

Primary outcomes

  1. Function of the knee

    Time frame: 24 months

    Knee Injury and Osteoarthritis Outcome Score (KOOS)

Secondary outcomes

  1. Patient-evaluated function of the knee and quality of life

    Time frame: 6 months, 12 months, 24 months

    Oxford-12-item knee score, WOMAC (as calculated from the KOOS)

  2. Clinician-evaluated function of the knee

    Time frame: 6 months, 12 months, 24 months

    Japanese Orthopaedic Association (JOA) score

  3. Health-related quality of life

    Time frame: 6 months, 12 months, 24 months

    Short Form-36 (SF-36)

  4. Range of motion (ROM)

    Time frame: 6 months, 12 months, 24 months

  5. Local and general pain

    Time frame: 6 months, 12 months, 24 months

    Visual Analogue Scale (VAS)

  6. Possibility and duration of the Japanese sitting style

    Time frame: 6 months, 12 months, 24 months

  7. Return to sport activities

    Time frame: 6 months, 12 months, 24 months

  8. Utilization

    Time frame: up to hospital discharge

    Length of hospital stay

  9. Evaluation of degenerated and regenerated cartilage

    Time frame: intraoperative and after 2 years

    ICRS and Outerbridge / Koshino)

  10. Radiological parameters

    Time frame: 6 months, 12 months, 24 months

    Kellgren-Lawrence classification, joint space narrowing, tibial slope, tibia vara

  11. Complications

    Time frame: 6 months, 12 months, 24 months

    Complications due to injections, complications due to heat therapy, complications due to medication (NSAIDs)

  12. Anatomical alignment

    Time frame: 6 months, 12 months, 24 months

    Femoro tibial angle (FTA)

Sponsors and collaborators

Lead sponsor

AO Clinical Investigation and Publishing Documentation

Other

Registry information

Official study title

A Focused Registry on the Conservative Treatment of Osteoarthritis of the Knee

Important dates

Study start
2014
Primary completion
2015
Study completion
2019
First posted
Mar 4, 2014
Registry last updated
Aug 12, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.